← Leaderboards
Milton D Rossman
University Of Pennsylvania
$1,436,646
Attributed
$1,671,206
Total exposure
7
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $236.3K · FY2005–14$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$1,671,206 · 7
By mechanism
M01$562,677 · 3
U01$469,120 · 1
R21$433,125 · 1
N01$198,596 · 1
P41$7,688 · 1
Top collaborators
- Ronald G Collman3 shared
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Shelley L Berger$32,851,390
- Daniel Benjamin Horton$8,748,567
- Rahim R Rizi$49,177,138
- Michael Francis Beers$18,247,357
- Arijitt Borthakur$976,404
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchPathologic ProcessSarcoidosisTissue Resource /RegistryDisease /Disorder Proneness /RiskOccupational Disease /DisorderPrognosisEnvironmental ToxicologyLymphocyte ProliferationAfrican AmericanGene Environment InteractionDosageEpidemiologyMetal PoisoningAir PollutionDisease /Disorder EtiologyBerylliosisLungInvestigationEtiologyAreaFibrosisInflammation
Grant awards (22)
GRADS Clinical Center: Studies in Sarcoidosis and Microbiomics Research$156,800
U01 · FY2014 · HL
GRADS Clinical Center: Studies in Sarcoidosis and Microbiomics Research$152,320
U01 · FY2013 · HL
GRADS Clinical Center: Studies in Sarcoidosis and Microbiomics Research$160,000
U01 · FY2012 · HL
DEVELOPMENT OF HYPERPOLARIZED HELIUM FOR ASSESSING INTERSTITIAL LUNG DISEASE$7,688
P41 · FY2011 · RR · contact PI
Development of Hyperpolarized Helium for Assessing ILD$196,875
R21 · FY2009 · HL · contact PI
Development of Hyperpolarized Helium for Assessing ILD$236,250
R21 · FY2008 · HL · contact PI
A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF INFLIXIMAB IN SARCOIDOSI$2,727
M01 · FY2005 · RR
Infliximab in subjects with Active Pulmonary Sarcoidosis$13,138
M01 · FY2004 · RR
CASE CONTROL ETIOLOGIC STUDY OF SARCOIDOSIS$124,146
M01 · FY2002 · RR
CHRONIC BERYLLIUM DISEASE AMONG BERYLLIUM EXPOSED WORKERS$124,146
M01 · FY2002 · RR
CHRONIC BERYLLIUM DISEASE AMONG BERYLLIUM EXPOSED WORKERS$124,146
M01 · FY2001 · RR
CASE CONTROL ETIOLOGIC STUDY OF SARCOIDOSIS$124,146
M01 · FY2001 · RR
CHRONIC BERYLLIUM DISEASE AMONG BERYLLIUM EXPOSED WORKERS$0
M01 · FY2001 · RR
CASE CONTROL ETIOLOGIC STUDY OF SARCOIDOSIS$0
M01 · FY2001 · RR
ETIOLOGY OF SARCOIDOSIS A CASE CONTROL STUDY$99,758
N01 · FY2000 · HR
ETIOLOGY OF SARCOIDOSIS A CASE CONTROL STUDY$98,838
N01 · FY2000 · HR
CASE CONTROL ETIOLOGIC STUDY OF SARCOIDOSIS$25,114
M01 · FY2000 · RR
CHRONIC BERYLLIUM DISEASE AMONG BERYLLIUM EXPOSED WORKERS$25,114
M01 · FY2000 · RR
CHRONIC BERYLLIUM DISEASE AMONG BERYLLIUM EXPOSED WORKERS$0
M01 · FY2000 · RR
CHRONIC BERYLLIUM DISEASE AMONG BERYLLIUM EXPOSED WORKERS$0
M01 · FY2000 · RR
CASE CONTROL ETIOLOGIC STUDY OF SARCOIDOSIS$0
M01 · FY2000 · RR
CASE CONTROL ETIOLOGIC STUDY OF SARCOIDOSIS$0
M01 · FY2000 · RR